Yashashwi Pokharel to Hypertension
This is a "connection" page, showing publications Yashashwi Pokharel has written about Hypertension.
Connection Strength
1.982
-
Ajja R, Suresh V, Wang S, Elashker A, Ordorica C, Bosworth HB, Moore JB, Rudd BN, Pokharel Y. A Framework to Decipher and Report Implementation Strategies and Pragmatic Attributes of Trial Design Domains From Pre-Implementation Studies Identified From a Systematic Review: A Methodological Study. J Eval Clin Pract. 2026 Mar; 32(2):e70403.
Score: 0.590
-
Ponir C, Annabathula R, Caldarera T, Penmetsa M, Seals A, Saha A, Moore JB, Bosworth HB, Ip EH, Shapiro MD, Pokharel Y. Availability of Specialty Services for Cardiovascular Prevention Practice in the Southeastern United States. South Med J. 2023 Nov; 116(11):848-856.
Score: 0.502
-
Pokharel Y, Karmacharya BM, Neupane D. Hypertension-A Silent Killer Without Global Bounds: What Next? J Am Coll Cardiol. 2022 Aug 23; 80(8):818-820.
Score: 0.463
-
Kramer J, Gupta A, Ellis S, Reed J, Pokharel Y, McWilliams A, Taylor YJ. Organizational Determinants to Hypertension Management: Adapting a Health Equity Framework to Examine Processes at Two Academic Health Systems. J Gen Intern Med. 2025 May; 40(6):1255-1264.
Score: 0.136
-
Jain V, Al Rifai M, Khan SU, Kalra A, Rodriguez F, Samad Z, Pokharel Y, Misra A, Sperling LS, Rana JS, Ullah W, Medhekar A, Virani SS. Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Study. J Am Heart Assoc. 2022 Aug 02; 11(15):e024414.
Score: 0.115
-
Patel KK, Arnold SV, Chan PS, Tang Y, Pokharel Y, Jones PG, Spertus JA. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial). Circ Cardiovasc Qual Outcomes. 2017 04; 10(4).
Score: 0.080
-
Timalsena D, Nakarmi CS, Mali S, Dhakal A, Bharati A, Bishwokarma A, Adhikari A, Poudel B, Rai BK, Baral PP, Bhattarai S, Dixit L, Pokharel Y, Rhodes E, Xu DR, Spiegelman D, Shrestha A. Factors associated with the adoption of the WHO Package of Essential Non-Communicable Diseases (PEN) Protocol 1 in primary healthcare settings in Nepal: a cross-sectional study. BMJ Open. 2025 Sep 10; 15(9):e090923.
Score: 0.036
-
Hira RS, Kataruka A, Akeroyd JM, Ramsey DJ, Pokharel Y, Gurm HS, Nasir K, Deswal A, Jneid H, Alam M, Ballantyne CM, Petersen LA, Virani SS. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
Score: 0.022
-
Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ, Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
Score: 0.019
-
deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. Circ Cardiovasc Genet. 2016 Jun; 9(3):240-9.
Score: 0.019